The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zerbaxa

1/0.5 gram(s) Powder for solution for infusion

Merck Sharp and Dohme LimitedEU/1/15/1032/001

Main Information

Trade NameZerbaxa
Active SubstancesCeftolozane sulfate
Tazobactam sodium
Strength1/0.5 gram(s)
Dosage FormPowder for solution for infusion
Licence HolderMerck Sharp and Dohme Limited
Licence NumberEU/1/15/1032/001

Group Information

ATC CodeJ01DI Other cephalosporins and penems
J01DI54 ZZZ ceftolozane and enzyme inhibitor

Status

Authorised/WithdrawnAuthorised
Licence Issued18/09/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back